Company: LNAI
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001731122-25-001316
Chunk: 900

Company: Lunai Bioworks Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 8
Chunk 900
---
 30,309,917 

    NON-CURRENT
    LIABILITIES: 

    Operating
    lease liabilities, net of current portion 
     424,547  
     842,389 
  
    Total
    Non-Current Liabilities 
     424,547  
     842,389 
  
    Total
    Liabilities 
     29,580,681  
     31,152,306 

    STOCKHOLDERS’
    EQUITY (DEFICIT) 

    Preferred
    stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding 
     —  
     — 
  
    Common
    stock, par value $0.0001, 350,000,000 shares authorized, 177,392,907 shares issued and outstanding at June 30, 2025; 158,452,644
    shares issued and outstanding at June 30, 2024 
     17,741  
     15,847 
  
    Additional
    paid-in capital 
     478,280,146  
     464,587,224 
  
    Accumulated
    deficit 
     (510,462,570) 
     (332,455,081)
  
    Accumulated
    other comprehensive (loss) 
     10,814,842  
     (170,846)
  
    Total
    Stockholders’ Equity (Deficit) 
     (21,349,841) 
     131,977,144 

    TOTAL
    LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) 
    $8,230,840  
    $163,129,450 

The accompanying notes are an integral part of these
consolidated financial statements.

F-4

LUNAI BIOWORKS INC. FKA: RENOVARO INC. AND SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF OPERATIONS

    For the Years Ended

    June 30,

    2025 
    2024

    Operating Expenses 

    General and administrative 
    $17,880,050  
    $24,557,608 
  
    Research and development 
     537,428  
     2,708,829 
  
    Intangible asset impairment